Cheryl A.. Conover

Cheryl A.. Conover's AcademicInfluence.com Rankings

Cheryl A.. Conover

Philosophy

#8826

World Rank

#12283

Historical Rank

Logic

#5842

World Rank

#7284

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Cheryl A.. Conover's Degrees

Doctorate Medicine Stanford University

Why Is Cheryl A.. Conover Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Cheryl A.. Conover's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Senescent intimal foam cells are deleterious at all stages of atherosclerosis (2016) (715)
The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. (1999) (688)
Insulin-like Growth Factor Binding Protein-1: Recent Findings and New Directions (1997) (505)
Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. (2001) (485)
The insulin-like growth factor axis: A review of atherosclerosis and restenosis. (2000) (450)
Regulation and Function of Insulin-Like Growth Factor-Binding Protein-1 (1993) (380)
Insulinlike growth factor-binding proteins. (1990) (290)
Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development (2004) (272)
Pregnancy‐associated plasma protein‐A (PAPP‐A) cleaves insulin‐like growth factor binding protein (IGFBP)‐5 independent of IGF: implications for the mechanism of IGFBP‐4 proteolysis by PAPP‐A (2001) (264)
Combined effects of insulin-like growth factor-1 and transforming growth factor-beta1 on periosteal mesenchymal cells during chondrogenesis in vitro. (2003) (260)
Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. (1992) (235)
Pregnancy-associated Plasma Protein-A2 (PAPP-A2), a Novel Insulin-like Growth Factor-binding Protein-5 Proteinase* (2001) (228)
Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. (1992) (219)
In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417. (2006) (195)
Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. (1999) (192)
Pregnancy-associated plasma protein-A (PAPP-A): a local regulator of IGF bioavailability through cleavage of IGFBPs. (2007) (178)
Expression of Recombinant Human Pregnancy-associated Plasma Protein-A and Identification of the Proform of Eosinophil Major Basic Protein as Its Physiological Inhibitor* (2000) (177)
Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies. (1993) (169)
Structural and biological characterization of bovine insulin-like growth factor binding protein-3. (1990) (158)
Functional insulin receptors on human epithelial ovarian carcinoma cells: implications for IGF-II mitogenic signaling. (2002) (150)
Insulin-Like Growth Factor Binding Protein-4 Protease Produced by Smooth Muscle Cells Increases in the Coronary Artery After Angioplasty (2001) (146)
Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation. (2002) (146)
Glucocorticoid regulation of insulin-like growth factor-binding protein expression in normal human osteoblast-like cells. (1994) (144)
Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells. (1993) (144)
Loss of pregnancy‐associated plasma protein A extends lifespan in mice (2007) (140)
Key questions and answers about pregnancy-associated plasma protein-A (2012) (138)
Insulin-like growth factor (IGF)-binding protein-3 blocks IGF-I-induced receptor down-regulation and cell desensitization in cultured bovine fibroblasts. (1991) (133)
Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: evidence for processing of cell-bound IGFBP-3. (1991) (132)
Genetic Deletion of Pregnancy-Associated Plasma Protein-A Is Associated With Resistance to Atherosclerotic Lesion Development in Apolipoprotein E–Deficient Mice Challenged With a High-Fat Diet (2007) (125)
Mutations in pregnancy‐associated plasma protein A2 cause short stature due to low IGF‐I availability (2016) (123)
Acid-activated insulin-like growth factor-binding protein-3 proteolysis in normal and transformed cells. Role of cathepsin D. (1994) (121)
Insulin-like growth factor binding proteins from cultured human fibroblasts. Characterization and hormonal regulation. (1989) (117)
Pregnancy-associated plasma protein-a is the insulin-like growth factor binding protein-4 protease secreted by human ovarian granulosa cells and is a marker of dominant follicle selection and the corpus luteum. (2001) (116)
Basal and regulated secretion of insulin-like growth factor binding proteins in osteoblast-like cells is cell line specific. (1992) (110)
Messenger ribonucleic acid levels of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein: expression in human reproductive and nonreproductive tissues. (1999) (110)
Evidence that the insulin-like growth factor binding protein-4 protease in human ovarian follicular fluid is pregnancy associated plasma protein-A. (1999) (110)
Insulin-like growth factor (IGF) binding protein-4 is both a positive and negative regulator of IGF activity in vivo. (2008) (110)
Cleavage Analysis of Insulin-like Growth Factor (IGF)-dependent IGF-binding Protein-4 Proteolysis and Expression of Protease-resistant IGF-binding Protein-4 Mutants (*) (1995) (109)
Endogenous cathepsin D-mediated hydrolysis of insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells. (1995) (108)
Pregnancy-Associated Plasma Protein-A (PAPP-A) in Ovine, Bovine, Porcine, and Equine Ovarian Follicles: Involvement in IGF Binding Protein-4 Proteolytic Degradation and mRNA Expression During Follicular Development. (2001) (107)
Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. (1998) (106)
Pregnancy-associated plasma protein-a is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events. (2006) (102)
Biological characterization of human epithelial ovarian carcinoma cells in primary culture: the insulin-like growth factor system. (1998) (99)
Effect of an anti-insulin-like growth factor I receptor antibody on insulin-like growth factor II stimulation of DNA synthesis in human fibroblasts. (1986) (97)
Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults. (1998) (95)
Regulation of insulin‐like growth factor binding protein 4 by a specific insulin‐like growth factor binding protein 4 proteinase in normal human osteoblast‐like cells: Implications in bone cell physiology (1994) (89)
Effects of androgens on the insulin-like growth factor system in an androgen-responsive human osteoblastic cell line. (1999) (87)
Cortisol increases plasma insulin-like growth factor binding protein-1 in humans. (1993) (86)
Pregnancy-associated plasma protein a gene expression as a target of inflammatory cytokines. (2004) (85)
Regulation of insulin-like growth factor binding protein-3 messenger ribonucleic acid expression by insulin-like growth factor I. (1992) (82)
A unique receptor-independent mechanism by which insulinlike growth factor I regulates the availability of insulinlike growth factor binding proteins in normal and transformed human fibroblasts. (1991) (81)
Insulin regulation of insulin-like growth factor-binding protein production in cultured HepG2 cells. (1990) (80)
Longevity and age-related pathology of mice deficient in pregnancy-associated plasma protein-A. (2010) (79)
Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina. (2006) (77)
Transforming Growth Factor‐β Regulation of the Insulin‐Like Growth Factor Binding Protein‐4 Protease System in Cultured Human Osteoblasts (2003) (76)
Regulation of insulin-like growth factor (IGF)-binding protein synthesis by insulin and IGF-I in cultured bovine fibroblasts. (1990) (76)
Localization and regulation of pregnancy-associated plasma protein a expression in healing human skin. (2003) (75)
Substrate specificity of the metalloproteinase pregnancy-associated plasma protein-A (PAPP-A) assessed by mutagenesis and analysis of synthetic peptides: substrate residues distant from the scissile bond are critical for proteolysis. (2002) (74)
Regulation of insulin-like growth factor binding protein-5 messenger ribonucleic acid expression and protein availability in rat osteoblast-like cells. (1993) (73)
Parathyroid hormone and parathyroid hormone-related peptide stimulate insulin-like growth factor-binding protein secretion by rat osteoblast-like cells through a adenosine 3',5'-monophosphate-dependent mechanism. (1991) (72)
Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity. (2000) (71)
Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis. (2002) (71)
Insulin-like growth factor-binding protein-1 expression in cultured human bone cells: regulation by insulin and glucocorticoid. (1996) (71)
Estrogen Effects on Insulin-Like Growth Factor Gene Expression in a Human Osteoblastic Cell Line with High Levels of Estrogen Receptor (1998) (71)
Cytokine stimulation of pregnancy-associated plasma protein A expression in human coronary artery smooth muscle cells: inhibition by resveratrol. (2006) (70)
Insulin‐like growth factor I/somatomedin‐C (IGF‐I/SM‐C) and glucocorticoids synergistically regulate mitosis in competent human fibroblasts (1983) (69)
Pregnancy-associated plasma protein-A2 (PAPP-A2): tissue expression and biological consequences of gene knockout in mice. (2011) (68)
Insulin-like growth factor-binding proteins and bone metabolism. (2008) (67)
Transgenic overexpression of pregnancy-associated plasma protein-A in murine arterial smooth muscle accelerates atherosclerotic lesion development. (2010) (66)
Regulation and physiological role of insulin-like growth factor binding proteins. (1996) (64)
A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma (1999) (64)
Comparative effects of somatomedin C and insulin on the metabolism and growth of cultured human fibroblasts (1985) (63)
The Lin12-Notch Repeats of Pregnancy-associated Plasma Protein-A Bind Calcium and Determine Its Proteolytic Specificity* (2004) (63)
Targeted disruption of the pregnancy-associated plasma protein-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia after vascular injury. (2006) (62)
Structural and immunological comparison of insulin-like growth factor binding proteins of cerebrospinal and amniotic fluids. (1989) (62)
Heterogeneity of insulin-like growth factor-I affinity for the insulin-like growth factor-II receptor: comparison of natural, synthetic and recombinant DNA-derived insulin-like growth factor-I. (1987) (62)
Insulin-like growth factor binding protein proteolysis in bone cell models. (1995) (61)
Effect of glucocorticoid on insulin-like growth factor (IGF) regulation of IGF-binding protein expression in fibroblasts. (1995) (61)
Factors regulating insulin-like growth factor-binding protein-3 binding, processing, and potentiation of insulin-like growth factor action. (1996) (60)
Lack of Functional Pregnancy-Associated Plasma Protein-A (PAPPA) Compromises Mouse Ovarian Steroidogenesis and Female Fertility1 (2010) (58)
Insulin and messenger ribonucleic acid expression of insulin receptor isoforms in ovarian follicles from nonhirsute ovulatory women and polycystic ovary syndrome patients. (2004) (58)
Disruption of insulin-like growth factor-II imprinting during embryonic development rescues the dwarf phenotype of mice null for pregnancy-associated plasma protein-A. (2005) (58)
The insulin-like growth factor-binding protein-4 (IGFBP-4)-IGFBP-4 protease system in normal human osteoblast-like cells: regulation by transforming growth factor-beta. (1994) (55)
Normal human osteoblast‐like cells consistently express genes for insulin‐like growth factors I and II but transformed human osteoblast cell lines do not (1995) (55)
Overexpression of pregnancy-associated plasma protein-A in ovarian cancer cells promotes tumor growth in vivo. (2011) (55)
Endocrine regulation of heat shock protein mRNA levels in long-lived dwarf mice (2009) (55)
Potential mechanism of estrogen-mediated decrease in bone formation: estrogen increases production of inhibitory insulin-like growth factor-binding protein-4. (1996) (54)
Indirect targeting of IGF receptor signaling in vivo by substrate-selective inhibition of PAPP-A proteolytic activity (2014) (54)
Mechanisms of Lysolipid Phosphate Effects on Cellular Survival and Proliferation (2000) (53)
The Role of Insulin-like Growth Factors and Binding Proteins in Bone Cell Biology (2002) (53)
Response of Bipotential Human Marrow Stromal Cells to Insulin-Like Growth Factors: Effect on Binding Protein Production, Proliferation, and Commitment to Osteoblasts and Adipocytes1. (1999) (52)
Insulin-Like Growth Factors Are Key Regulators of T Helper 17 Regulatory T Cell Balance in Autoimmunity. (2020) (52)
Resistance to age-dependent thymic atrophy in long-lived mice that are deficient in pregnancy-associated plasma protein A (2009) (52)
Differential regulation of pregnancy associated plasma protein-A in human coronary artery endothelial cells and smooth muscle cells. (2008) (52)
Effects of aliphatic diamines on rat liver ornithine decarboxylase activity. (1978) (50)
A Novel Neutralizing Antibody Targeting Pregnancy-Associated Plasma Protein-A Inhibits Ovarian Cancer Growth and Ascites Accumulation in Patient Mouse Tumorgrafts (2015) (49)
Role of extracellular matrix in insulin-like growth factor (IGF) binding protein-2 regulation of IGF-II action in normal human osteoblasts. (2003) (47)
Detecting vulnerable plaque using peripheral blood: inflammatory and cellular markers. (2003) (46)
Surface association of pregnancy-associated plasma protein-A accounts for its colocalization with activated macrophages. (2007) (45)
Growth hormone/insulin-like growth factor-I axis in aging: a summary of a National Institutes of Aging-Sponsored Symposium. (1997) (45)
In vitro studies of insulin-like growth factor I and bone. (2000) (45)
Lack of Growth Hormone Effect on Insulin-Associated Suppression of Insulinlike Growth Factor Binding Protein 1 in Humans (1990) (42)
Regulation of pregnancy-associated plasma protein-A expression in cultured human osteoblasts. (2004) (42)
Response of bipotential human marrow stromal cells to insulin-like growth factors: effect on binding protein production, proliferation, and commitment to osteoblasts and adipocytes. (1999) (42)
Hormonal control of the replication of human fetal fibroblasts: Role of somatomedin C/insulin‐like growth factor I (1986) (41)
Insulin-like growth factor receptors and binding protein in rat neuroblastoma cells. (1989) (40)
Effect of insulin on kinetics of sugar transport in heart muscle. (1978) (39)
Pregnancy associated plasma protein-A is necessary for expeditious fracture healing in mice. (2007) (37)
Impact of Pregnancy‐Associated Plasma Protein‐A Deletion on the Adult Murine Skeleton (2007) (37)
Expression of recombinant murine pregnancy-associated plasma protein-A (PAPP-A) and a novel variant (PAPP-Ai) with differential proteolytic activity. (2002) (36)
Targeted Inhibition of Pregnancy-Associated Plasma Protein-A Activity Reduces Atherosclerotic Plaque Burden in Mice (2016) (36)
Insulin-like growth factor-binding protein-1 response to insulin during suppression of endogenous insulin secretion. (1993) (36)
Alterations in insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis in transformed osteoblastic cells. (1995) (35)
Regulation of insulin-like growth factor (IGF)-binding protein-4 availability in normal human osteoblast-like cells: role of endogenous IGFs. (1995) (34)
Insulin‐like growth factor II binding and action in human fetal fibroblasts (1987) (34)
IGF system in children with congenital disorders of glycosylation (2009) (33)
Frequent homozygous deletions in the FRA3B region in tumor cell lines still leave the FHIT exons intact (1998) (33)
PAPP-A and cancer. (2018) (33)
Molecular regulation of the IGF-binding protein-4 protease system in human fibroblasts: identification of a novel inducible inhibitor. (2002) (33)
Cultured human fibroblasts secrete insulin-like growth factor IA prohormone. (1989) (33)
Bioactivity of a 29-Kilodalton Insulin-Like Growth Factor Binding Protein-3 Fragment Present in Excess in Chronic Renal Failure Serum (1997) (32)
Transforming Growth Factor-β and Forskolin Increase All Classes of Insulin-like Growth Factor-I Transcripts in Normal Human Osteoblast-like Cells (1995) (32)
The insulin-like growth factor/insulin system in epithelial ovarian cancer. (2003) (31)
Use of site-specific antibodies to characterize the circulating form of big insulin-like growth factor II in patients with hepatitis C-associated osteosclerosis. (2002) (30)
Human hepatoma cells synthesize and secrete insulin-like growth factor Ia prohormone under growth hormone control (1993) (30)
Preferential impact of pregnancy-associated plasma protein-A deficiency on visceral fat in mice on high-fat diet. (2013) (30)
The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential (2016) (30)
Regulation of Gonadotropin Releasing Hormone Release by Neuropeptide Y at the Median Eminence during the Preovulatory Period in Ewes (2003) (30)
Pregnancy-associated plasma protein-A (PAPP-A) in ovine, bovine, porcine, and equine ovarian follicles: involvement in IGF binding protein-4 proteolytic degradation and mRNA expression during follicular development. (2001) (29)
Pregnancy-associated plasma protein-A expression in human breast cancer. (2014) (29)
Pregnancy‐associated plasma protein‐A (PAPP‐A) expression and insulin‐like growth factor binding protein‐4 protease activity in normal and malignant ovarian surface epithelial cells (2004) (28)
PAPP‐A: a new anti‐aging target? (2010) (28)
Pregnancy-associated plasma protein-a is involved in matrix mineralization of human adult mesenchymal stem cells and angiogenesis in the chick chorioallontoic membrane. (2005) (28)
Pregnancy-Associated Plasma Protein-A (PAPP-A) in Ewing Sarcoma: Role in Tumor Growth and Immune Evasion. (2019) (28)
Metabolic consequences of pregnancy-associated plasma protein-A deficiency in mice: exploring possible relationship to the longevity phenotype. (2008) (28)
Phorbol ester tumor promoters regulate insulin-like growth factor-binding protein-4 proteolysis. (1993) (28)
Density‐associated loss of functional receptors for somatomedin‐C/insulinlike growth factor I (SM‐C/IGF‐I) on cultured human fibroblast monolayers (1984) (27)
Heterogeneous role of caspase-8 in fenretinide-induced apoptosis in epithelial ovarian carcinoma cell lines. (2003) (26)
Substrate Utilization in Perfused Skeletal Muscle (1979) (26)
Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. (1998) (26)
Pregnancy-associated plasma protein-A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy. (2008) (26)
Recommendations for nomenclature of the insulin-like growth factor binding protein (IGFBP) superfamily. (1998) (26)
Stress-activated signaling pathways mediate the stimulation of pregnancy-associated plasma protein-A expression in cultured human fibroblasts. (2006) (25)
PAPP-A proteolytic activity enhances IGF bioactivity in ascites from women with ovarian carcinoma (2015) (25)
Pregnancy associated plasma protein-A and risk stratification of patients presenting with chest pain in the emergency department. (2007) (25)
Insulin and Interleukin-4 Induce Desensitization to the Mitogenic Effects of Insulin-like Growth Factor-I (1997) (24)
PAPP‐A: a promising therapeutic target for healthy longevity (2016) (24)
Regional variation in adipogenesis and IGF regulatory proteins in the fetal baboon. (2009) (24)
Irreversible inhibition of mamalian and yeast S-adenosylmethionine decarboxylase by 1,1'- (methylethanediylidenedinitrilo)-bis (3-aminoguanidine). (1976) (24)
Ornithine decarboxylase activity in insulin-deficient states. (1980) (24)
Insulin-like growth factor-II enhancement of human fibroblast growth via a nonreceptor-mediated mechanism. (1994) (23)
Characterization and partial purification of the insulin-like growth factor (IGF)-dependent IGF binding protein-4-specific protease from human fibroblast conditioned media. (1999) (23)
Pregnancy-associated Plasma Protein A (PAPP-A) Modulates the Early Developmental Rate in Zebrafish Independently of Its Proteolytic Activity* (2013) (23)
Stanniocalcin-2 overexpression reduces atherosclerosis in hypercholesterolemic mice. (2016) (23)
Role of PAPP-A in aging and age-related disease (2013) (22)
Preferential expression of PAPPA in human preadipocytes from omental fat. (2014) (21)
Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteins. (1997) (20)
Inducible knock out of pregnancy-associated plasma protein-a gene expression in the adult mouse: effect on vascular injury response. (2013) (20)
Normal somatomedin-C/insulin-like growth factor I binding and action in cultured human fibroblasts from Turner syndrome. (1983) (20)
Cellular actions of insulin-like growth factor binding protein-3. (1993) (19)
Heparin-binding mechanism of the IGF2/IGF-binding protein 2 complex. (2014) (18)
Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy. (2013) (18)
Erratum: Lack of growth hormone effect on insulin-associated suppression of insulinlike growth factor binding protein 1 in humans (Diabetes (1990) 39 (1251-1256)) (1991) (18)
Inducible knockdown of pregnancy‐associated plasma protein‐A gene expression in adult female mice extends life span (2017) (17)
Cell Surface Detachment of Pregnancy-associated Plasma Protein-A Requires the Formation of Intermolecular Proteinase-Inhibitor Disulfide Bonds and Glycosaminoglycan Covalently Bound to the Inhibitor* (2007) (16)
Effects of mutated pregnancy-associated plasma protein-a on atherosclerotic lesion development in mice. (2013) (16)
The Insulin-Like Growth Factor System in the Long-Lived Naked Mole-Rat (2015) (16)
Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis. (2020) (16)
Inducible reduction in pregnancy-associated plasma protein-A gene expression inhibits established atherosclerotic plaque progression in mice. (2014) (16)
Posttranslational Modification of the IGF Binding Proteins (1999) (15)
PAPP-A and the IGF system in Atherosclerosis - What's Up, What's Down? (2019) (15)
Transforming growth factor-beta and forskolin increase all classes of insulin-like growth factor-I transcripts in normal human osteoblast-like cells. (1995) (15)
Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer. (2004) (15)
The Association of Early Dietary Supplementation with Vitamin E with the Incidence of Ulcerative Dermatitis in Mice on a C57BL/6 Background: Diet and Ulcerative Dermatitis in Mice. (2010) (14)
Insulin-like growth factor (IGF)-I and IGF-II contribute differentially to the phenotype of pregnancy associated plasma protein-A knock-out mice. (2011) (13)
The IGF-p53 connection in cancer. (2018) (13)
Effects of insulin-like growth factor-I on cultured human coronary artery smooth muscle cells. (2003) (13)
PAPP-A in normal human mesangial cells: effect of inflammation and factors related to diabetic nephropathy. (2016) (13)
Somatomedin C-binding and action in fibroblasts from aged and progeric subjects. (1985) (12)
Aging alters somatomedin-C-dexamethasone synergism in the stimulation of deoxyribonucleic acid synthesis and replication of cultured human fibroblasts. (1985) (12)
Characterization of the enzymatic specificity of the IGF-dependent insulin-like growth factor binding protein-4 (IGFBP-4) protease. (2000) (12)
A quantitative PCR measurement of messenger RNA expression of IGF-I, IGF-II and IGFBP-5 in human skeletal muscle. (1999) (12)
Constitutive expression of pregnancy-associated plasma protein-A in arterial smooth muscle reduces the vascular response to injury in vivo. (2013) (12)
Physiological Concentrations of Insulin Induce Cellular Desensitization to the Mitogenic Effects of Insulin-Like Growth Factor I (1994) (11)
Insulin-like growth factor I induction of c-myc expression in bovine fibroblasts can be blocked by antecedent insulin receptor activation. (1998) (11)
Longevity is not influenced by prenatal programming of body size (2010) (11)
Discrepancies in insulin-like growth factor signaling? No, not really. (2016) (11)
Comparative gene expression and phenotype analyses of skeletal muscle from aged wild-type and PAPP-A-deficient mice (2016) (10)
Cellular characterization of human epicardial adipose tissue: highly expressed PAPP‐A regulates insulin‐like growth factor I signaling in human cardiomyocytes (2019) (10)
Tissue-specific changes in pregnancy associated plasma protein-A expression with age in mice (2014) (10)
Abnormal IGF-Binding Protein Profile in the Bone Marrow of Multiple Myeloma Patients (2016) (9)
Potentiation of insulin-like growth factor action by insulin-like growth factor binding protein-3: studies of underlying mechanism. (1993) (9)
Impaired Synergism between Somatomedin C/Insulin-Like Growth Factor I and Dexamethasone in the Growth of Fibroblasts from a Patient with Insulin Resistance (1987) (9)
Differential binding of 125I-IGF-I preparations to human fibroblast monolayers. (1988) (9)
Differential effects of glucocorticoids on insulin‐like growth factor I action in cultured human fibroblasts (1995) (9)
Regulation of Ornithine Decarboxylase in Skeletal Muscle: Evidence for the Involvement of an Insulin-dependent Serum Factor (1981) (8)
Characterization of mouse pericardial fat: regulation by PAPP-A. (2018) (7)
Effect of diabetes on the induction of ornithine decarboxylase by refeeding. (1979) (7)
Pregnancy-associated plasma protein-A deficiency improves survival of mice on a high fat diet (2015) (6)
Somatomedin C/insulin-like growth factor I binding and action in human fibroblasts aged in culture: impaired synergism with dexamethasone. (1987) (6)
Transforming growth factor-beta1 modulates insulin-like growth factor binding protein-4 expression and proteolysis in cultured periosteal explants. (2010) (6)
Effects of suppressing bioavailability of insulin‐like growth factor on age‐associated intervertebral disc degeneration (2020) (6)
Hodgkin's lymphoma manifesting with hypoglycemia. (2003) (5)
The Development Of Political Attitudes In Young Children (1969) (5)
Pregnancy-associated plasma protein-A modulates the anabolic effects of parathyroid hormone in mouse bone. (2015) (5)
Overcoming platinum resistance in ovarian cancer by targeting pregnancy-associated plasma protein-A (2018) (5)
Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy (2014) (5)
Secretion of insulin-like growth factor binding protein-1 from individual hepatocytes. (1994) (4)
Increased activity of the metalloproteinase PAPP-A promotes diabetes-induced glomerular hypertrophy. (2022) (3)
Genetic and Pharmacological Inhibition of PAPP-A Protects Against Visceral Obesity in Mice. (2020) (3)
Serum glucocorticoids have persistent and controlling effects on insulinlike growth factor i action under serum-free assay conditions in cultured human fibroblasts (1989) (3)
BMS-554417, an inhibitor of the insulin-like growth factor I receptor and insulin receptor, inhibits proliferation and induces mitochondrial pathway-mediated apoptosis in cancer cell lines (2005) (2)
Hormonal regulation of IGF binding proteins (1989) (2)
Pregnancy‐associated plasma protein‐A (PAPP‐A) is a key component of an interactive cellular mechanism promoting pulmonary fibrosis (2022) (2)
Senescence induces proteolytically-active PAPP-A secretion and association with extracellular vesicles in human pre-adipocytes (2022) (2)
Myocardial and Peripheral Ischemia Causes an Increase in Circulating Pregnancy-Associated Plasma Protein-A in Non-atherosclerotic, Non-heparinized Pigs (2015) (1)
Mice deficient in PAPPA show resistance to the development of diabetic nephropathy (2013) (1)
The Stanniocalcin-PAPP-A-IGFBP-IGF Axis. (2023) (1)
Pregnancy associated plasma protein-A levels are elevated in patients with unstable angina (2003) (1)
PAPP-A affects tendon structure and mechanical properties. (2015) (1)
Partial Characterization of an Insulin-dependent Serum Factor that Regulates Ornithine Decarboxylase in Skeletal Muscle (1982) (1)
Marker of inflammation (2002) (1)
Receptor for Lysophosphatidic Acid in Ovarian Cancer Endothelial Differentiation Gene-encoded G Protein-coupled Distinctive Expression and Functions of the Type 4 Updated (1999) (0)
LBA1A Novel Neutralizing Antibody Targeting PAPP-A Inhibits Tumor Growth and Ascites in Primary Patient Ovarian Tumorgrafts (Ovatars) (2015) (0)
The Association of Early Dietary Supplementation with Vitamin E with the Incidence of Ulcerative Dermatitis in Mice on a C 57 BL / 6 Background by (2012) (0)
Motor and memory testing of long-lived pregnancy-associated plasma protein--a knock-out mice. (2014) (0)
Abstract 4817: Regression of malignant ascites via PAPP-A inhibition in ovarian cancer patient-derived xenograft model (2017) (0)
Proteolytic cleavage of an Insulin-like Growth Factor Binding Protein (IGFBP) by a novel serine protease that contains an IGFBP-like domain (1998) (0)
OR13,74 Longevity and age-related pathology of mice deficient in pregnancy-associated plasma protein-A (2010) (0)
Insulin-like growth factor (IGF)-II/IGF-binding proteins in constitutionally tall children. (2003) (0)
PL03 PAPP-A AND IGFBP CONTROL (2006) (0)
Regulation and Factor Binding Physiological Proteins Role of Insulin-Like Growth (0)
Effect of Pregnancy Associated Plasma Protein- A Overexpression on Atherosclerotic Plaque Morphology in Mice (2019) (0)
A New Syndrome Associated with Mutations in the Gene for Pregnancy-Associated Plasma Protein A2 (PAPP-A2) Causing Proportionate Short Stature, High Circulating IGF-I, IGFBP-3, and ALS, Mild Microcephaly, thin Long Bones and Decreased Bone Mineral Density in two Unrelated Families (2015) (0)
Lysolipid phosphate receptors and effects in ovarian and breast cancer cells (1999) (0)
SUN-591 PAPP-A Inhibition - a Novel Anti-Obesity Therapeutic Approach (2020) (0)
Marker for inflammatory states (2002) (0)
Circulating insulin-like growth factor (IGF) system adaptations in hibernating brown bears indicate increased tissue IGF availability. (2022) (0)
Functional competence of T cells and resistance to thymic involution in long-lived mice deficient in pregnancy-associated plasma protein A (PAPPA) (86.2) (2009) (0)
Pregnancy associated plasma protein-A is preferentially expressed in plaque of patients with restenosis (2002) (0)
Mrna levels of insulin-like growth factor 1 and II and binding proteins 4 and 5 in human skeletal muscle (1996) (0)
Insulin-like Growth Factor Binding Proteins from Cultured Human Fibroblasts (2013) (0)
Brain-specific PAPP-A knock-out mice? (2021) (0)
IGFs and cellular aging (1997) (0)
Effect of insulin on kinetics of glucose transport (1975) (0)
OR6,35 Heparin binding properties of the IGF-II/IGFBP-2 complex (2010) (0)
Aalborg Universitet Abnormal IGF-Binding Protein Profile in the Bone Marrow of Multiple Myeloma Patients (2016) (0)
Regulation of ornithine decarboxylase (ODC) in starvation and diabetes: Role of insulin (1978) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Cheryl A.. Conover?

Cheryl A.. Conover is affiliated with the following schools:

Boston University